Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125366682 | 12536668 | 2 | F | 20160621 | 20160919 | 20160707 | 20160921 | EXP | US-PFIZER INC-2016324627 | PFIZER | 69.00 | YR | M | Y | 108.00000 | KG | 20160921 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125366682 | 12536668 | 1 | PS | TIKOSYN | DOFETILIDE | 1 | 250 UG, 2X/DAY | D | 20931 | 250 | UG | CAPSULE, HARD | BID | ||||||
| 125366682 | 12536668 | 2 | SS | TIKOSYN | DOFETILIDE | 1 | 500 UG, UNK | D | 20931 | 500 | UG | CAPSULE, HARD | |||||||
| 125366682 | 12536668 | 3 | C | ASPIRIN /00002701/ | ASPIRIN | 1 | 81 MG, 1X/DAY | 0 | 81 | MG | QD | ||||||||
| 125366682 | 12536668 | 4 | C | ALLOPURINOL. | ALLOPURINOL | 1 | 300 MG, 1X/DAY | 0 | 300 | MG | QD |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125366682 | 12536668 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125366682 | 12536668 | Death |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |